Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Which Indices Are Most Followed By Investors highlights the benchmarks that attract the most attention from market participants and why their popularity matters.
27,878 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
U.S. stocks surged, with the S&P 500 hitting a fresh peak and a new company joining the $1 trillion market-cap circle...
The shift in AI spending is reshaping winners and losers. This article explains why a power-semiconductor-focused com...
Rivian is plotting a bold three-year arc that hinges on scale, software, and partnerships. This guide breaks down the...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
As stock market volatility rages, the S&P 500 sits at a high valuation that history warns could verge on trouble. Thi...
This guide helps investors decode Workiva's 2025 earnings landscape. Learn which metrics matter, how to read manageme...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
MicroStrategy disclosed its first Bitcoin sale under Michael Saylor’s strategy, selling 32 BTC to fund preferred stoc...
ServiceNow stock sits in the mid-$90s as AI disruption reshapes enterprise software. This article lays out a fresh 20...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...